Document is current
Any future updates will be listed below
-
Authors
Scott, Daniel C.
Dharuman, Suresh https://orcid.org/0000-0002-5491-6677
Griffith, Elizabeth
Chai, Sergio C. https://orcid.org/0000-0002-8257-8599
Ronnebaum, Jarrid
King, Moeko T. https://orcid.org/0000-0002-4192-8337
Tangallapally, Rajendra
Lee, Chan https://orcid.org/0000-0002-5512-8146
Gee, Clifford T. https://orcid.org/0000-0001-7181-603X
Yang, Lei https://orcid.org/0000-0002-3060-0790
Li, Yong
Loudon, Victoria C.
Lee, Ha Won https://orcid.org/0000-0001-5382-9646
Ochoada, Jason
Miller, Darcie J.
Jayasinghe, Thilina https://orcid.org/0000-0003-3436-0795
Paulo, Joao A. https://orcid.org/0000-0002-4291-413X
Elledge, Stephen J. https://orcid.org/0000-0001-7923-6283
Harper, J. Wade https://orcid.org/0000-0002-6944-7236
Chen, Taosheng https://orcid.org/0000-0001-6420-3809
Lee, Richard E. https://orcid.org/0000-0002-2397-0443
Schulman, Brenda A. https://orcid.org/0000-0002-3083-1126
-
Funding
Funding for this research was provided by:
Max-Planck-Gesellschaft (Schulman department)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NIH P30CA021765)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (5RO1CA247365, 5RO1CA247365)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health (R01GM132129)
Howard Hughes Medical Institute (Investigator)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (NIH R01AG11085, NIH R01AG11085)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
- License Information
-
More Information
Article History
Received: 15 April 2024
Accepted: 27 September 2024
First Online: 12 October 2024
Competing interests
: D.C.S., S.D., E.G., S.C.C., J.R., R.T., C.T.G., H.W.L., J.O., T.C., R.E.L., and B.A.S. are listed as co-inventors in patent filings associated with the technologies described in this manuscript. D.C.S. and B.A.S. are co-inventors of intellectual property that is unrelated to this work (DCN1 inhibitors licensed to Cinsano). J.W.H. is a founder and consultant for Caraway Therapeutics and is a scientific advisory board member for Lyterian Therapeutics. S.J.E. is a founder of, and holds equity in, TScan Therapeutics and Immune ID. S.J.E. is also founder of MAZE Therapeutics, and Mirimus and serves on the scientific advisory board of TSCAN Therapeutics, and MAZE Therapeutics. In accordance with Partners HealthCare’s conflict of interest policies, the Partners Office for Interactions with Industry has reviewed SJE’s financial interest in TSCAN and determined that it creates no significant risk to the welfare of participants in this study or to the integrity of this research. B.A.S. is a member of the scientific advisory boards of Biotheryx and Proxygen. The remaining authors declare no competing interests.
